1. Home
  2. RNST vs INDV Comparison

RNST vs INDV Comparison

Compare RNST & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

N/A

Current Price

$39.83

Market Cap

3.6B

Sector

Finance

ML Signal

N/A

Logo Indivior PLC

INDV

Indivior PLC

N/A

Current Price

$35.64

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNST
INDV
Founded
1904
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.2B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
RNST
INDV
Price
$39.83
$35.64
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$46.67
★ $49.50
AVG Volume (30 Days)
647.4K
★ 2.2M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
★ 2.38%
N/A
EPS Growth
N/A
★ 8100.00
EPS
1.88
★ 2.78
Revenue
N/A
★ $1,239,000,000.00
Revenue This Year
$11.39
$7.50
Revenue Next Year
$6.20
$5.07
P/E Ratio
$21.34
★ $12.59
Revenue Growth
N/A
★ 4.29
52 Week Low
$33.04
$27.68
52 Week High
$44.54
$42.81

Technical Indicators

Market Signals
Indicator
RNST
INDV
Relative Strength Index (RSI) 45.45 53.02
Support Level $38.84 $32.90
Resistance Level $40.98 $35.93
Average True Range (ATR) 0.80 1.41
MACD 0.06 0.12
Stochastic Oscillator 36.61 68.87

Price Performance

Historical Comparison
RNST
INDV

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: